A Japanese patient with neonatal biotin-responsive basal ganglia disease.

IF 1 Q4 GENETICS & HEREDITY Human Genome Variation Pub Date : 2022-09-29 DOI:10.1038/s41439-022-00210-z
Mizuki Kobayashi, Yuichi Suzuki, Maki Nodera, Ayako Matsunaga, Masakazu Kohda, Yasushi Okazaki, Kei Murayama, Takanori Yamagata, Hitoshi Osaka
{"title":"A Japanese patient with neonatal biotin-responsive basal ganglia disease.","authors":"Mizuki Kobayashi,&nbsp;Yuichi Suzuki,&nbsp;Maki Nodera,&nbsp;Ayako Matsunaga,&nbsp;Masakazu Kohda,&nbsp;Yasushi Okazaki,&nbsp;Kei Murayama,&nbsp;Takanori Yamagata,&nbsp;Hitoshi Osaka","doi":"10.1038/s41439-022-00210-z","DOIUrl":null,"url":null,"abstract":"<p><p>Biotin-responsive basal ganglia disease (BBGD) with SLC19A3 mutation was first reported in 1998, and over 30 mutations have been reported. We report a neonatal BBGD case with sudden-onset feeding difficulty and impaired consciousness. Encephalopathy resolved after the initiation of biotin and thiamine treatment. Genetic testing revealed a novel heterozygous mutation [c.384_387del, p.Tyr128fs];[c.265 A > C, p.Ser89Arg] in SLC19A3. Early treatment for BBGD is essential, especially with onset in the neonatal or early infancy period.</p>","PeriodicalId":36861,"journal":{"name":"Human Genome Variation","volume":"9 1","pages":"35"},"PeriodicalIF":1.0000,"publicationDate":"2022-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522647/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Genome Variation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s41439-022-00210-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 1

Abstract

Biotin-responsive basal ganglia disease (BBGD) with SLC19A3 mutation was first reported in 1998, and over 30 mutations have been reported. We report a neonatal BBGD case with sudden-onset feeding difficulty and impaired consciousness. Encephalopathy resolved after the initiation of biotin and thiamine treatment. Genetic testing revealed a novel heterozygous mutation [c.384_387del, p.Tyr128fs];[c.265 A > C, p.Ser89Arg] in SLC19A3. Early treatment for BBGD is essential, especially with onset in the neonatal or early infancy period.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
日本新生儿生物素反应性基底神经节病1例。
生物素反应性基底神经节病(BBGD)伴SLC19A3突变于1998年首次报道,目前已报道了30多种突变。我们报告一个新生儿BBGD病例突发性喂养困难和意识受损。开始生物素和硫胺素治疗后,脑病消失。基因检测发现一种新的杂合突变[c。384 _387del p.Tyr128fs]; [c。[6] [A] [C], [p] [C]。早期治疗BBGD至关重要,特别是在新生儿或婴儿期早期发病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Human Genome Variation
Human Genome Variation Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
2.30
自引率
0.00%
发文量
39
审稿时长
13 weeks
期刊最新文献
Simultaneous surgery for gastrostomy and laryngotracheal separation in a patient with Tay‒Sachs disease. Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study. CFAP43 variant in persistent respiratory symptoms after hematopoietic cell transplantation. A case of CDKL5 deficiency disorder with a novel intragenic multi-exonic duplication. A mild case of Cockayne syndrome with a novel start-loss variant of ERCC8.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1